544 – FDA Approved Psychotrop IC Medication S Listing for Common Psychiatri C Illnesses in Current us Pacific Military Medicine and Comparison with Europe

Abstract

Introduction:

What are the FDA and EMEA approved Psychotropic Medications for Psychiatric Illnesses? What do these approval processes mean?

Objectives:

Describe the process for FDA/ EMEA approval of drugs used to treat psychiatric disordres, identify disorders of DSM-IV TR commonly seen in Medicine, present currently FDA/EMEA approved Psychotropic Medications for Psychiatric Illnesses in International Medicine.

To identify psychiatric disorders of DSM-IV TR commonly seen in Medicine and have access to a FDA/EMEA approved Psychotropic Medications.

Aims:

The FDA and its European Counterpart, the EMEA are recognized for enforcing two of the world's most rigorous review processes, determining what medications are safe/effective, which makes their approval a meaningful title to patients. A readily accessible list of DSM-IV TR Psychiatric disorders with the corresponding FDA and EMEA approved medications listed would help communication between providers and patients and prevent bad outcomes. Currently, no such document is readily available.

Methods:

Review of most commonly seen psychiatric disorders in International Medicine. Review of the current FDA Orange book for current FDA approved Psychotrop Medications for Common Psychiatric Illnesses.

Results:

A list of DSM-IV TR Psychiatric disorders commonly seen in Medicine with the corresponding FDA/EMEA approved medications listed.

Conclusions:

To create a user friendly document listing common DSM-IV TR Psychiatric disorders seen in the US military setting with the corresponding FDA approved psychotropic medications to aid healthcare providers, and educate patients about the significance of using a medication for its FDA approved diagnoses versus “off-label” prescribing, and to compare this process to the EMEA process.